本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apogee Therapeutics

47.46
+3.147.08%
盘后47.500.0400+0.08%16:20 EDT
成交量:50.68万
成交额:2,350.73万
市值:27.70亿
市盈率:-13.22
高:47.71
开:44.71
低:43.51
收:44.32
数据加载中...
2024/05/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/06

SEC问询函

Form CORRESP - Correspondence
2024/03/06

SEC问询函

Form CORRESP - Correspondence
2024/03/05

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/05

重要事件披露

Form 8-K - Current report
2024/03/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/03

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/28

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/28

重要事件披露

Form 8-K - Current report